NuCana plcNCNA

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$1.32
Market cap
$5.5M
P/E
—
Revenue (FY)
—
Net income
-$29.4M
Dividend yield
—
1-year total return
-66.8%
Net margin
—
Revenue growth
—
Debt / equity
—

What NuCana plc does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Net income-$30.7M-$40.5M-$32.0M-$27.6M-$19.0M-$29.4M
Free cash flow-$22.0M-$23.9M-$23.2M-$26.4M-$19.1M-$7.5M

More on NCNA.

Figures from NuCana plc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.